Chapter 5 : Animal Models of Pneumococcal Colonization

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Animal Models of Pneumococcal Colonization, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap05-2.gif


This chapter describes existing animal models of colonization and reviews what these various models have taught us about pneumococcal carriage. The most widely studied model of pneumococcal colonization is the mouse model. Infant rat models of pneumococcal colonization have also been described in several studies. A buccal mucosa model was also developed to evaluate the impact of ambient temperatures on pneumococcal colonization. The major limitation of chinchilla model is the relative lack of chinchilla reagents, as well as the expense. Animal models have provided information about the contribution of specific bacterial components to colonization, the first step in the pathogenesis of all pneumococcal disease. Different laboratories have used different mouse strains, which often vary in susceptibility to pneumococcal colonization and disease. Murine models of pneumococcal colonization have helped enhance the understanding of acquired immunity to pneumococcal colonization. The infant rat model of intralitter spread was used to evaluate the impact of systemic anticapsular antibodies in the prevention of pneumococcal colonization. The administration of bacterial polysaccharide immune globulin (from hyperimmune sera obtained from adults immunized with pneumococcal, type b, and meningococcal pure-polysaccharide vaccines) to infant rats reduced the likelihood of pneumococcal colonization by about 50%. The development of purified-protein vaccines or whole-cell vaccines, however, faces several challenges, including the inherent difficulty of studying colonization in animals that normally do not carry in their respiratory trees.

Citation: Malley R, Weiser J. 2008. Animal Models of Pneumococcal Colonization, p 59-66. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch5

Key Concept Ranking

Major Histocompatibility Complex
Pneumococcal Conjugate Vaccine
Acute Otitis Media
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Abramson, J. S.,, G. S. Giebink, and, P. G. Quie. 1982. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect. Immun. 36:289296.
2. Albiger, B.,, S. Dahlberg,, A. Sandgren,, F. Wartha,, K. Beiter,, H. Katsuragi,, S. Akira,, S. Normark, and, B. Henriques-Normark. 2007. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol. 9:633644.
3. Albiger, B.,, A. Sandgren,, H. Katsuragi,, U. Meyer-Hoffert,, K. Beiter,, F. Wartha,, M. Hornef,, S. Normark, and, B. H. Normark. 2005. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell. Microbiol. 7:16031615.
4. Balachandran, P.,, A. Brooks-Walter,, A. Virolainen-Julkunen,, S. K. Hollingshead, and, D. E. Briles. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70:25262534.
5. Barocchi, M. A.,, J. Ries,, X. Zogaj,, C. Hemsley,, B. Albiger,, A. Kanth,, S. Dahlberg,, J. Fernebro,, M. Moschioni,, V. Masignani,, K. Hultenby,, A. R. Taddei,, K. Beiter,, F. Wartha,, A. von Euler,, A. Covacci,, D. W. Holden,, S. Normark,, R. Rappuoli, and, B. Henriques-Normark. 2006. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. USA 103:28572862.
6. Dave, S.,, S. Carmicle,, S. Hammerschmidt,, M. K. Pangburn, and, L. S. McDaniel. 2004. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J. Immunol. 173:471477.
7. Giebink, G. S. 1999. Otitis media: the chinchilla model. Microb. Drug Resist. 5:5772.
8. Giebink, G. S.,, I. K. Berzins,, S. C. Marker, and, G. Schiffman. 1980. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30:445450.
9. Giebink, G. S.,, M. L. Ripley,, D. A. Shea,, P. F. Wright, and, M. M. Paparella. 1985. Clinical-histopathological correlations in experimental otitis media: implications for silent otitis media in humans. Pediatr. Res. 19:389396.
10. Gray, B. M.,, M. E. Turner, and, H. C. Dillon, Jr. 1982. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am. J. Epidemiol. 116:692703.
11. Hammerschmidt, S.,, S. R. Talay,, P. Brandtzaeg, and, G. S. Chhatwal. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:11131124.
12. Hammerschmidt, S.,, M. P. Tillig,, S. Wolff,, J. P. Vaerman, and, G. S. Chhatwal. 2000. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol. Microbiol. 36:726736.
13. Hava, D. L., and, A. Camilli. 2002. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45:13891406.
14. Hava, D. L.,, C. J. Hemsley, and, A. Camilli. 2003. Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J. Bacteriol. 185:413421.
15. Hogberg, L.,, P. Geli,, H. Ringberg,, E. Melander,, M. Lipsitch, and, K. Ekdahl. 2007. Age- and serogroup-related differences in the observed duration of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45:948952.
16. Jones, E. E.,, P. L. Alford,, A. L. Reingold,, H. Russell,, M. E. Keeling, and, C. V. Broome. 1984. Predisposition to invasive pneumococcal illness following parainfluenza type 3 virus infection in chimpanzees. J. Am. Vet. Med. Assoc. 185:13511353.
17. Kadioglu, A.,, S. Taylor,, F. Iannelli,, G. Pozzi,, T. J. Mitchell, and, P. W. Andrew. 2002. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70:28862890.
18. Kilian, M., and, J. Reinholdt. 2005. Immunoglobulin A1 proteases of pathogenic and commensal bacteria of the respiratory tract, p. 119130. In J. P. Nataro (ed.), Colonization of Mucosal Surfaces. ASM Press, Washington, DC.
19. King, S. J.,, K. R. Hippe, and, J. N. Weiser. 2006. Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol. Microbiol. 59:961974.
20. Kormos, R.,, C. Boesch,, M. I. Bakarr, and T. Butynski (ed.). 2003. West African Chimpanzees: Status Survey and Conservation Action Plan. International Union for Conservation of Nature and Natural Resources, Gland, Switzerland.
21. LeMieux, J.,, D. L. Hava,, A. Basset, and, A. Camilli. 2006. RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect. Immun. 74:24532456.
22. Lexau, C. A.,, R. Lynfield,, R. Danila,, T. Pilishvili,, R. Facklam,, M. M. Farley,, L. H. Harrison,, W. Schaffner,, A. Reingold,, N. M. Bennett,, J. Hadler,, P. R. Cieslak, and, C. G. Whitney. 2005. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:20432051.
23. Lysenko, E. S.,, A. J. Ratner,, A. L. Nelson, and, J. N. Weiser. 2005. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1:e1.
24. Magee, A. D., and, J. Yother. 2001. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69:37553761.
25. Malley, R.,, P. Henneke,, S. C. Morse,, M. J. Cieslewicz,, M. Lipsitch,, C. M. Thompson,, E. Kurt-Jones,, J. C. Paton,, M. R. Wessels, and, D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA. 100:19661971.
26. Malley, R.,, M. Lipsitch,, A. Stack,, R. Saladino,, G. Fleisher,, S. Pelton,, C. Thompson,, D. E. Briles, and, P. Anderson. 2001. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by encapsulated pneumococci. Infect. Immun. 69:48704873.
27. Malley, R.,, S. C. Morse,, L. C. C. Leite,, A. P. Mattos Areas,, P. L. Ho,, F. S. Kubrusly,, I. C. Almeida, and, P. Anderson. 2004. Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant. Infect. Immun. 72:42904292.
28. Malley, R.,, A. Srivastava,, M. Lipsitch,, C. M. Thompson,, C. Watkins,, A. Tzianabos, and, P. W. Anderson. 2006. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect. Immun. 74:21872195.
29. Malley, R.,, A. M. Stack,, M. L. Ferretti,, C. M. Thompson, and, R. A. Saladino. 1998. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. J. Infect. Dis. 178:878882.
30. Malley, R.,, K. Trzcinski,, A. Srivastava,, C. M. Thompson,, P. W. Anderson, and, M. Lipsitch. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA. 102:48484853.
31. Manco, S.,, F. Hernon,, H. Yesilkaya,, J. C. Paton,, P. W. Andrew, and, A. Kadioglu. 2006. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun. 74:40144020.
32. McCool, T. L.,, T. R. Cate,, G. Moy, and, J. N. Weiser. 2002. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195:359365.
33. McCool, T. L.,, T. R. Cate,, E. I. Tuomanen,, P. Adrian,, T. J. Mitchell, and, J. N. Weiser. 2003. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect. Immun. 71:57245732.
34. McCool, T. L., and, J. N. Weiser. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72:58075813.
35. Nelson, A. L.,, A. M. Roche,, J. M. Gould,, K. Chim,, A. J. Ratner, and, J. N. Weiser. 2007. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 75:8390.
36. Orihuela, C. J.,, G. Gao,, K. P. Francis,, J. Yu, and, E. I. Tuomanen. 2004. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190:16611669.
37. Oztuna, F.,, T. Ozlu,, Y. Bulbul,, K. Buruk, and, M. Topbas. 2006. Does cold environment affect Streptococcus pneumoniae adherence to rat buccal epithelium? Respiration 73:546551.
38. Pericone, C. D.,, D. Bae,, M. Shchepetov,, T. McCool, and, J. N. Weiser. 2002. Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J. Bacteriol. 184:43924399.
39. Philipp, M. T.,, J. E. Purcell,, D. S. Martin,, W. R. Buck,, G. B. Plauche,, E. P. Ribka,, P. DeNoel,, P. Hermand,, L. E. Leiva,, G. J. Bagby, and, S. Nelson. 2006. Experimental infection of rhesus macaques with Streptococcus pneumoniae: a possible model for vaccine assessment. J. Med. Primatol. 35:113122.
40. Proctor, M., and, P. J. Manning. 1990. Production of immunoglobulin A protease by Streptococcus pneumoniae from animals. Infect. Immun. 58:27332737.
41. Rijneveld, A. W.,, S. Weijer,, S. Florquin,, P. Speelman,, T. Shimizu,, S. Ishii, and, T. van der Poll. 2004. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J. Infect. Dis. 189:711716.
42. Rosenow, C.,, P. Ryan,, J. N. Weiser,, S. Johnson,, P. Fontan,, A. Ortqvist, and, H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819829.
43. Rubins, J. B., and, E. N. Janoff. 1998. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:2127.
44. Solleveld, H. A.,, M. J. van Zwieten,, P. J. Heidt, and, P. M. van Eerd. 1984. Clinicopathologic study of six cases of meningitis and meningoencephalitis in chimpanzees (Pan troglodytes). Lab. Anim. Sci. 34:8690.
45. Straus, W. L., Jr. 1937. The visceral anatomy of an infant chimpanzee. J. Mammal. 18:501507.
46. Takashima, K.,, K. Tateda,, T. Matsumoto,, Y. Iizawa,, M. Nakao, and, K. Yamaguchi. 1997. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65:257260.
47. Tong, H. H.,, L. E. Blue,, M. A. James, and, T. F. DeMaria. 2000. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect. Immun. 68:921924.
48. Tong, H. H.,, L. M. Fisher,, G. M. Kosunick, and, T. F. De-Maria. 2000. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann. Otol. Rhinol. Laryngol. 109:10211027.
49. Tong, H. H.,, I. Grants,, X. Liu, and, T. F. DeMaria. 2002. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection. Infect. Immun. 70:42924301.
50. Tong, H. H.,, J. N. Weiser,, M. A. James, and, T. F. De-Maria. 2001. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect. Immun. 69:602606.
51. Trzcinski, K.,, C. Thompson,, R. Malley, and, M. Lipsitch. 2004. Intranasal exposure to Streptococcus pneumoniae and protection against intranasal colonization: impact of capsular serotype on colonization and on homologous and heterologous protection, p. 106. Fourth Int. Symp. Pneumococci Pneumococcal Dis., Helsinki, Finland, 9 to 13 May 2004.
52. Trzcinski, K.,, C. M. Thompson,, A. M. Gilbey,, C. G. Dowson, and, M. Lipsitch. 2006. Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J. Infect. Dis. 193:12961303.
53. van Rossum, A. M.,, E. S. Lysenko, and, J. N. Weiser. 2005. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect. Immun. 73:77187726.
54. Weiser, J. N.,, R. Austrian,, P. K. Sreenivasan, and, H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:25822589.
55. Whatmore, A. M.,, S. J. King,, N. C. Doherty,, D. Sturgeon,, N. Chanter, and, C. G. Dowson. 1999. Molecular characterization of equine isolates of Streptococcus pneumoniae: natural disruption of genes encoding the virulence factors pneumolysin and autolysin. Infect. Immun. 67:27762782.
56. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, N. M. Bennett,, R. Lynfield,, A. Reingold,, P. R. Cieslak,, T. Pilishvili,, D. Jackson,, R. R. Facklam,, J. H. Jorgensen, and, A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:17371746.
57. Wu, H. Y.,, A. Virolainen,, B. Mathews,, J. King,, M. W. Russell, and, D. E. Briles. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23:127137.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error